HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Charles Schwartz Selected Research

ciproxifan

9/2006N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain.
8/2002Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Charles Schwartz Research Topics

Disease

12Narcolepsy
01/2022 - 04/2008
10Disorders of Excessive Somnolence (Hypersomnia)
01/2022 - 04/2008
8Cataplexy
01/2022 - 04/2008
6Sleepiness
01/2022 - 04/2008
4Headache (Headaches)
01/2021 - 01/2017
3Schizophrenia (Dementia Praecox)
04/2007 - 08/2002
2Sleep Initiation and Maintenance Disorders (Insomnia)
01/2021 - 01/2020
2Apnea
01/2021 - 01/2020
2Nausea
01/2020 - 01/2017
2Epilepsy (Aura)
07/2016 - 07/2013
2Psychotic Disorders (Schizoaffective Disorder)
09/2006 - 01/2003
1Obstructive Sleep Apnea
01/2020
1Fatigue
01/2020
1Body Weight (Weight, Body)
01/2020
1Vertigo (Positional Vertigo)
01/2020
1Hallucinations (Hallucination)
10/2019
1Spontaneous Abortion (Miscarriage)
10/2019
1Sleep Paralysis
10/2019
1Anaphylaxis (Anaphylactic Shock)
07/2018
1Overweight
07/2018
1Cardiac Arrhythmias (Arrythmia)
12/2017
1Inflammation (Inflammations)
01/2017
1Generalized Epilepsy
07/2016
1Seizures (Absence Seizure)
07/2016
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
11/2013
1Abdominal Pain (Pain, Abdominal)
11/2013
1Brain Diseases (Brain Disorder)
07/2013
1Sleep Wake Disorders
10/2012
1Sleep Deprivation
12/2010
1Mental Disorders (Mental Disorder)
08/2003
1Substance-Related Disorders (Drug Abuse)
01/2003
1Catalepsy
08/2002

Drug/Important Bio-Agent (IBA)

16pitolisantIBA
01/2022 - 04/2007
12Histamine (Histamine Dihydrochloride)FDA Link
01/2022 - 01/2003
4Histamine H3 Receptors (Histamine H3 Receptor)IBA
01/2020 - 11/2013
3OrexinsIBA
10/2012 - 04/2008
2Cytidine Triphosphate (CTP)IBA
01/2022 - 12/2021
2ciproxifanIBA
09/2006 - 08/2002
2Dopamine (Intropin)FDA LinkGeneric
08/2003 - 01/2003
1Epinephrine (Adrenaline)FDA LinkGeneric
07/2018
13-(2-carboxyindol-3-yl)propionic acidIBA
12/2017
1Pharmaceutical PreparationsIBA
12/2017
1Histamine H4 ReceptorsIBA
01/2017
1Anticonvulsants (Antiepileptic Drugs)IBA
07/2016
1Amphetamine (Amfetamine)FDA LinkGeneric
11/2013
1Modafinil (Provigil)FDA Link
11/2013
1tele-methylhistamineIBA
10/2012
1NeuropeptidesIBA
04/2008
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
09/2006
1Haloperidol (Haldol)FDA LinkGeneric
08/2002

Therapy/Procedure

2Therapeutics
01/2021 - 01/2017
1Continuous Positive Airway Pressure
01/2020
1Intramuscular Injections
07/2018